Pliant Therapeutics (PLRX) Insider Trading & Ownership $12.43 -0.42 (-3.27%) (As of 11/15/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Pliant Therapeutics (NASDAQ:PLRX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage6.40%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)5Amount OfInsider Selling(Last 12 Months)$1.67 M Get PLRX Insider Trade Alerts Want to know when executives and insiders are buying or selling Pliant Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address PLRX Insider Buying and Selling by Quarter Ad Weiss RatingsThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin conference in Nashville … Where he told an adoring crowd that the U.S. would become … “The crypto capital of the planet and the Bitcoin superpower of the world.”Click here to find out more about what could be Trump and JD Vance’s favorite coin. Pliant Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails7/10/2024Bernard CoulieCEOSell38,710$11.56$447,487.60 7/10/2024Eric LefebvreInsiderSell12,319$11.56$142,407.64 7/10/2024Keith Lamont CummingsCFOSell10,911$11.56$126,131.16 7/10/2024Mike OuimetteGeneral CounselSell7,656$11.56$88,503.36 1/17/2024Bernard CoulieCEOSell25,721$17.23$443,172.83 1/17/2024Hans HullInsiderSell9,786$17.23$168,612.78 1/17/2024Keith Lamont CummingsCFOSell9,781$17.23$168,526.63 1/17/2024Mike OuimetteGeneral CounselSell5,197$17.23$89,544.31 (Data available from 1/1/2013 forward) PLRX Insider Trading Activity - Frequently Asked Questions Who is on Pliant Therapeutics's Insider Roster? The list of insiders at Pliant Therapeutics includes Bernard Coulie, Eric Lefebvre, Hans Hull, Keith Lamont Cummings, and Mike Ouimette. Learn more on insiders at PLRX. What percentage of Pliant Therapeutics stock is owned by insiders? 6.40% of Pliant Therapeutics stock is owned by insiders. Learn more on PLRX's insider holdings. Which Pliant Therapeutics insiders have been selling company stock? The following insiders have sold PLRX shares in the last 24 months: Bernard Coulie ($6,436,751.41), Eric Lefebvre ($3,377,967.95), Hans Hull ($429,992.78), Keith Lamont Cummings ($2,149,054.00), and Mike Ouimette ($1,528,640.55). How much insider selling is happening at Pliant Therapeutics? Insiders have sold a total of 602,109 Pliant Therapeutics shares in the last 24 months for a total of $13,922,406.69 sold. Pliant Therapeutics Key ExecutivesDr. Bernard Coulie M.B.A. (Age 57)M.D., Ph.D., President, CEO & Director Compensation: $996.97kDr. Keith Lamont Cummings M.B.A. (Age 47)M.D., Chief Financial Officer Compensation: $684.14k1 recent tradesMr. Mike Ouimette J.D. (Age 51)General Counsel & Corporate Secretary Compensation: $606.03k1 recent tradesMr. Johannes P. Hull (Age 49)Chief Business Officer Compensation: $602.51kDr. Éric Lefebvre M.D. (Age 60)Chief Medical Officer Compensation: $734.41kDr. Rik DerynckScientific Founder & Member of Scientific Advisory BoardMr. Dean Sheppard M.D.Scientific Founder & Member of Scientific Advisory BoardMr. Bill DeGrado Ph.D.Scientific Founder & Member of Scientific Advisory BoardMr. Hal Chapman M.D.Scientific Founder & Member of Scientific Advisory BoardMr. Craig D. MuirInterim Chief Technology Officer More Insider Trading Tools from MarketBeat Related Companies ANNX Insider Trades FGEN Insider Trades ARVN Insider Trades MORF Insider Trades BHC Insider Trades MRUS Insider Trades RYTM Insider Trades APLS Insider Trades EWTX Insider Trades XENE Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking OnInsiders Are Buying High-Yielding Delek Logistics Partners This page (NASDAQ:PLRX) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pliant Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pliant Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
